Humulin N Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients
Condition:   Hyperglycemia Interventions:   Drug: Human insulin isophane, Humulin N (Eli Lilly);   Drug: Standard of care;   Drug: Insulin lispro, Humalog (Eli Lilly) in insulin pump Sponsors:   Medical University of Vienna;   Charite University, Berlin, Germany;   Medical University of Graz;   Hospital del Mar Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2018 Category: Research Source Type: clinical trials